Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Acromegaly × pegvisomant × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Pituitary Neoplasms 1 Brain Neoplasms 1 Acromegaly 1

Interventions

pasireotide 2 lanreotide 2 Cabergoline 2 pegvisomant 1 Transcranial Magnetic Stimulation 1 Tissue Banks 1 Surgical Procedures, Operative 1 Solutions 1 Radiosurgery 1 Octreotide 1 Observation 1 Magnetic Resonance Spectroscopy 1 Injections 1 Dosage Forms 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00376064 2017-03-06

Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly

Novartis

Phase 4 Completed

Acromegaly, Brain Neoplasms, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡